Fresenius | FRE - Interest Expense On Debt



Fresenius reported 86M in Interest Expense on Debt for its fiscal quarter ending in June of 2025.


Interest Expense On Debt Change Date
Akzo Nobel EUR 68M 26M Jun/2025
Alcon AG USD 49M 1000K Mar/2025
AstraZeneca 303M 126M Jun/2025
BASF EUR 222M 4M Jun/2025
Bayer 495M 89M Jun/2025
Beiersdorf EUR 7.5M 4.5M Jun/2025
DaVita Healthcare Partners USD 146.06M 11.01M Jun/2025
Demant 435M 27M Jun/2025
E.ON EUR 407M 154M Jun/2025
Essilor EUR 147M 102.5M Jun/2025
Fresenius 86M 30M Jun/2025
Fresenius Medical Care EUR 96.58M 15.58M Jun/2025
Getinge 173M 21M Dec/2024
Givaudan CHF 28M 28M Jun/2024
GlaxoSmithKline 184M 22M Jun/2025
GN Store Nord 297M 69M Jun/2025
GRIFOLS EUR 202.71M 94.07M Jun/2024
Hikma Pharmaceutical 22M 9M Jun/2024
Lonza CHF 70M 11M Dec/2024
Merck 79M 1000K Jun/2025
Novartis USD 289M 19M Jun/2025
Philips 80M 24M Jun/2025
Roche Holding CHF 311.5M 1000K Dec/2024
RWE EUR 145M 22M Mar/2025
Sanofi 148M 65M Jun/2025
Smith & Nephew 69M 1000K Jun/2025